Stay updated on Immunologic Response to Pembrolizumab in Melanoma Clinical Trial

Sign up to get notified when there's something new on the Immunologic Response to Pembrolizumab in Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Immunologic Response to Pembrolizumab in Melanoma Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    12 days ago
    Change Detected
    Summary
    The record history now shows the latest revision (v3.6.3) and removes the previous revision (v3.6.2), reflecting an update to the study record's version history.
    Difference
    0.1%
    Check dated 2026-07-04T13:16:03.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    Revision tag updated from v3.6.0 to v3.6.2 in the record history, indicating a page or software update. This change reflects backend/interface updates rather than alterations to the study data.
    Difference
    0.1%
    Check dated 2026-06-27T06:15:34.000Z thumbnail image
  4. Check
    33 days ago
    Change Detected
    Summary
    The history shows a recruitment status update indicating no longer looking for participants, and a new Revision: v3.6.0 was recorded (replacing the previous v3.5.5).
    Difference
    0.5%
    Check dated 2026-06-13T04:27:43.000Z thumbnail image
  5. Check
    40 days ago
    Change Detected
    Summary
    A new revision tag v3.5.5 was added to the history. The previous tag v3.5.4 was removed from the list.
    Difference
    0.1%
    Check dated 2026-06-05T23:50:07.000Z thumbnail image
  6. Check
    62 days ago
    Change Detected
    Summary
    A new revision (v3.5.4) appears in the page's revision history, indicating an update to the site's underlying content or layout. This change is a behind-the-scenes update and does not alter the study information shown.
    Difference
    0.1%
    Check dated 2026-05-15T15:58:34.000Z thumbnail image
  7. Check
    83 days ago
    Change Detected
    Summary
    ClinicalTrials.gov’s displayed revision version was updated from v3.5.2 to v3.5.3, indicating a site/interface version change rather than an edit to the study’s content.
    Difference
    0.1%
    Check dated 2026-04-24T06:10:14.000Z thumbnail image

Stay in the know with updates to Immunologic Response to Pembrolizumab in Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Immunologic Response to Pembrolizumab in Melanoma Clinical Trial page.